| Product Code: ETC9972437 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The US orthopedic biomaterial import market in 2024 saw consistent growth with a CAGR of 5.65% from 2020 to 2024. Key exporting countries such as Denmark, Israel, and Ireland continued to be major contributors, along with Austria and Mexico. Despite this, the market maintained a moderate concentration with a relatively stable Herfindahl-Hirschman Index (HHI). The growth rate in 2024 was 3.19%, indicating a steady expansion of orthopedic biomaterial imports into the US. This data suggests a positive outlook for the industry in terms of both volume and diversity of supply sources.

The United States Orthopedic Biomaterial Market is a rapidly growing sector driven by an increasing aging population and rising incidences of musculoskeletal disorders. Biomaterials such as ceramics, polymers, metals, and composites are widely used in orthopedic surgeries to repair and replace damaged bones and joints. The market is also influenced by advancements in technology, such as 3D printing and nanotechnology, which enable the development of innovative biomaterials with enhanced properties. Key players in the US orthopedic biomaterial market include Medtronic, Stryker Corporation, Zimmer Biomet Holdings, and Johnson & Johnson. With a strong focus on research and development, the market is expected to continue expanding as demand for orthopedic procedures grows, creating opportunities for market players to introduce new and improved biomaterial products.
The US Orthopedic Biomaterial Market is experiencing significant growth due to increasing incidences of musculoskeletal disorders and a rising aging population. The market is witnessing a trend towards the development of advanced biomaterials with enhanced biocompatibility and durability to improve patient outcomes and reduce the risk of implant failure. Opportunities exist for companies investing in research and development to create innovative biomaterials for orthopedic applications, such as bioresorbable materials and 3D-printed implants. Additionally, the growing demand for minimally invasive surgeries and personalized orthopedic solutions is driving the adoption of biomaterials in the orthopedic field. Companies offering customized biomaterial solutions tailored to individual patient needs are well-positioned to capitalize on this evolving market landscape.
In the US Orthopedic Biomaterial Market, challenges include stringent regulatory requirements for approval, high costs associated with research and development, competition from traditional orthopedic devices, and the need for continuous innovation to meet evolving patient demands. Additionally, the market faces issues related to the limited availability of skilled healthcare professionals for specialized procedures using orthopedic biomaterials, as well as the complexity of integrating these materials into existing healthcare systems. Ensuring the safety and efficacy of orthopedic biomaterials, managing supply chain disruptions, and addressing concerns related to long-term performance and durability are also key challenges faced by companies operating in this market. Overall, navigating these obstacles requires a strategic approach that balances innovation, regulatory compliance, cost-effectiveness, and patient outcomes.
The United States Orthopedic Biomaterial Market is primarily driven by the increasing prevalence of musculoskeletal disorders such as osteoarthritis and osteoporosis among the aging population. The rising demand for minimally invasive surgical procedures and advancements in biomaterial technologies are also key drivers propelling market growth. Additionally, the growing adoption of biocompatible materials in orthopedic surgeries to improve patient outcomes and reduce post-operative complications is fueling the market expansion. Moreover, the escalating number of sports injuries and road accidents leading to orthopedic injuries are contributing to the increasing demand for orthopedic biomaterials in the US healthcare sector. These factors, coupled with the continuous research and development activities by key market players, are expected to drive the growth of the US Orthopedic Biomaterial Market in the foreseeable future.
In the United States, the orthopedic biomaterial market is influenced by various government policies aimed at ensuring the safety, efficacy, and quality of medical devices. The Food and Drug Administration (FDA) regulates orthopedic biomaterials through the approval process, ensuring that products meet rigorous standards before reaching the market. Additionally, reimbursement policies set by the Centers for Medicare and Medicaid Services (CMS) play a significant role in determining the accessibility and affordability of orthopedic biomaterials for patients. The government`s focus on promoting innovation and research in the healthcare sector also impacts the orthopedic biomaterial market, encouraging the development of advanced materials and technologies to improve patient outcomes and address evolving healthcare needs. Overall, government policies in the US orthopedic biomaterial market are designed to safeguard patient health, drive innovation, and support market growth.
The future outlook for the US Orthopedic Biomaterial Market appears promising, driven by factors such as the increasing prevalence of orthopedic disorders, growing geriatric population, advancements in biomaterial technology, and rising demand for minimally invasive surgical procedures. The market is expected to witness steady growth as healthcare providers and patients alike recognize the benefits of using biomaterials in orthopedic applications, including reduced infection rates, improved biocompatibility, and enhanced patient outcomes. Additionally, ongoing research and development efforts aimed at expanding the range of biomaterial options available for orthopedic surgeries are likely to further propel market expansion in the coming years. Overall, the US Orthopedic Biomaterial Market is poised for significant growth and innovation in the foreseeable future.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Orthopedic Biomaterial Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Orthopedic Biomaterial Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Orthopedic Biomaterial Market - Industry Life Cycle |
3.4 United States (US) Orthopedic Biomaterial Market - Porter's Five Forces |
3.5 United States (US) Orthopedic Biomaterial Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Orthopedic Biomaterial Market Revenues & Volume Share, By Material, 2021 & 2031F |
3.7 United States (US) Orthopedic Biomaterial Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 United States (US) Orthopedic Biomaterial Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) Orthopedic Biomaterial Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of orthopedic disorders and injuries in the US |
4.2.2 Growing aging population leading to higher demand for orthopedic procedures |
4.2.3 Technological advancements in orthopedic biomaterials leading to improved patient outcomes |
4.3 Market Restraints |
4.3.1 High cost associated with orthopedic biomaterials |
4.3.2 Stringent regulatory requirements for approval of orthopedic biomaterials |
4.3.3 Limited reimbursement policies for orthopedic biomaterials |
5 United States (US) Orthopedic Biomaterial Market Trends |
6 United States (US) Orthopedic Biomaterial Market, By Types |
6.1 United States (US) Orthopedic Biomaterial Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Orthopedic Biomaterial Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Orthopedic Biomaterial Market Revenues & Volume, By Metal, 2021- 2031F |
6.1.4 United States (US) Orthopedic Biomaterial Market Revenues & Volume, By Non- Metal, 2021- 2031F |
6.2 United States (US) Orthopedic Biomaterial Market, By Material |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Orthopedic Biomaterial Market Revenues & Volume, By Ceramics and Bioactive Glasses, 2021- 2031F |
6.2.3 United States (US) Orthopedic Biomaterial Market Revenues & Volume, By Polymers, 2021- 2031F |
6.2.4 United States (US) Orthopedic Biomaterial Market Revenues & Volume, By Calcium Phosphate Cements, 2021- 2031F |
6.2.5 United States (US) Orthopedic Biomaterial Market Revenues & Volume, By Composites, 2021- 2031F |
6.3 United States (US) Orthopedic Biomaterial Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Orthopedic Biomaterial Market Revenues & Volume, By Orthobiologics, 2021- 2031F |
6.3.3 United States (US) Orthopedic Biomaterial Market Revenues & Volume, By Orthopedic Implants, 2021- 2031F |
6.3.4 United States (US) Orthopedic Biomaterial Market Revenues & Volume, By Joint Replacement/Reconstruction, 2021- 2031F |
6.3.5 United States (US) Orthopedic Biomaterial Market Revenues & Volume, By Viscosupplementation, 2021- 2031F |
6.3.6 United States (US) Orthopedic Biomaterial Market Revenues & Volume, By Bio-Resorbable Tissue Fixation, 2021- 2031F |
6.4 United States (US) Orthopedic Biomaterial Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Orthopedic Biomaterial Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United States (US) Orthopedic Biomaterial Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 United States (US) Orthopedic Biomaterial Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Orthopedic Biomaterial Market Import-Export Trade Statistics |
7.1 United States (US) Orthopedic Biomaterial Market Export to Major Countries |
7.2 United States (US) Orthopedic Biomaterial Market Imports from Major Countries |
8 United States (US) Orthopedic Biomaterial Market Key Performance Indicators |
8.1 Adoption rate of new orthopedic biomaterial technologies in the US market |
8.2 Number of orthopedic procedures utilizing biomaterials |
8.3 Patient satisfaction rates with orthopedic biomaterial implants |
9 United States (US) Orthopedic Biomaterial Market - Opportunity Assessment |
9.1 United States (US) Orthopedic Biomaterial Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Orthopedic Biomaterial Market Opportunity Assessment, By Material, 2021 & 2031F |
9.3 United States (US) Orthopedic Biomaterial Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 United States (US) Orthopedic Biomaterial Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) Orthopedic Biomaterial Market - Competitive Landscape |
10.1 United States (US) Orthopedic Biomaterial Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Orthopedic Biomaterial Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |